BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28120182)

  • 1. Expression of YAP1 in aggressive thyroid cancer.
    Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
    Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
    [No Abstract]   [Full Text] [Related]  

  • 2. miR‑205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells.
    Li D; Wang Q; Li N; Zhang S
    Mol Med Rep; 2018 Aug; 18(2):1674-1681. PubMed ID: 29845281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
    Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
    Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated carcinoma of the thyroid: an aggressive type of tumour arising from thyroid follicular epithelium.
    Sakamoto A
    Curr Top Pathol; 1997; 91():45-50. PubMed ID: 9018915
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer.
    Onda M; Li D; Suzuki S; Nakamura I; Takenoshita S; Brogren CH; Stampanoni S; Rampino N
    Clin Cancer Res; 2002 Sep; 8(9):2870-4. PubMed ID: 12231529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
    Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
    Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
    Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
    Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
    Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
    Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
    Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
    Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.